Filing Details

Accession Number:
0000096943-23-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-04 18:54:02
Reporting Period:
2022-12-30
Accepted Time:
2023-01-04 18:54:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
96943 Teleflex Inc TFX Surgical & Medical Instruments & Apparatus (3841) 231147939
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1552476 Liam Kelly 550 E. Swedesford Road
Wayne PA 19087
Chairman, President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-30 16,343 $78.62 32,153 No 4 M Direct
Common Stock Disposition 2022-12-30 16,340 $250.03 15,813 No 4 S Direct
Common Stock Disposition 2022-12-30 3 $251.00 15,810 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option / (Right to Buy) Disposition 2022-12-30 16,343 $0.00 16,343 $78.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,040 2023-02-26 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,531 Indirect By Helen Kelly 2021 Irrevocable Trust
Footnotes
  1. Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 26, 2022.
  2. This transaction was executed in multiple trades at prices ranging from $250.00 to $250.16. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Exercisable for one-third of the shares on each of 2/26/2014, 2/26/2015 and 2/26/2016.